Global X Genomics & Biotechnology ETF Rating $7.68 -0.30 (-3.76%) Closing price 04/3/2025 03:59 PM EasternExtended Trading$7.74 +0.07 (+0.85%) As of 07:07 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ratings Stock AnalysisChartHoldingsOptions ChainOwnershipRatingsShort InterestTrendsBuy This Stock Global X Genomics & Biotechnology ETF Aggregate Rating and Price Target (2025)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.GNOM Aggregate RatingModerate Buy 2.67Holdings in GNOM have an aggregate rating of Moderate Buy based on 510 analyst ratings issued in the past year covering 38 companies (95.7% of the portfolio).GNOM Aggregate Price Target$7.68High Prediction$7.68Average Prediction$7.68Low Prediction$7.68Holdings in GNOM have an aggregate price target of $7.68 and a range of $7.68 to $7.68 covering 38 companies (95.7% of the portfolio).GNOM Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy5 Buy rating(s)Moderate Buy21 Moderate Buy rating(s)Hold11 Hold rating(s)Reduce1 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by Global X Genomics & Biotechnology ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 39 GNOM Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings6.27%NTRANatera$138.71-3.1%3.7204 of 5 stars3.00$178.12 28.4%16Insider TradeNews Coverage5.08%BMRNBioMarin Pharmaceutical$67.48-1.2%4.8948 of 5 stars2.71$94.00 39.3%24Analyst DowngradeNews CoveragePositive News4.88%VCYTVeracyte$28.47-5.5%4.4866 of 5 stars2.70$43.40 52.4%10News CoverageGap Down4.52%QGENQiagen$40.40+1.0%3.4911 of 5 stars2.30$47.71 18.1%10High Trading Volume4.50%AAgilent Technologies$109.63-5.5%4.2981 of 5 stars2.46$150.83 37.6%13Ex-DividendInsider TradeNews CoveragePositive NewsGap DownHigh Trading Volume4.45%CRSPCRISPR Therapeutics$32.66-4.5%3.1207 of 5 stars2.48$73.11 123.8%21Gap Down4.33%TECHBio-Techne$54.86-6.0%4.8223 of 5 stars2.56$81.25 48.1%9Short Interest ↑Positive NewsGap Down4.31%BNTXBioNTech$92.01-1.4%2.734 of 5 stars2.89$143.44 55.9%18Analyst ForecastGap Down4.27%LEGNLegend Biotech$32.88-1.1%2.5849 of 5 stars2.92$79.00 140.3%12Short Interest ↓News CoveragePositive News4.26%ALNYAlnylam Pharmaceuticals$262.16-1.8%4.281 of 5 stars2.77$316.25 20.6%26Analyst ForecastAnalyst Revision3.86%BEAMBeam Therapeutics$16.46-10.9%3.116 of 5 stars3.00$49.45 200.5%14Insider TradeShort Interest ↑Gap DownHigh Trading Volume3.77%ARWRArrowhead Pharmaceuticals$12.06-5.0%3.1321 of 5 stars2.60$41.44 243.7%10Gap Down3.53%RAREUltragenyx Pharmaceutical$35.13-0.7%4.3609 of 5 stars2.93$92.79 164.1%14News CoveragePositive NewsGap Down3.37%RNAAvidity Biosciences$28.10-5.6%2.5592 of 5 stars3.00$66.69 137.3%13Insider TradeGap Down3.02%MRNAModerna$25.73-7.2%4.2855 of 5 stars2.04$59.00 129.3%24Gap Down3.01%GILDGilead Sciences$112.39+0.4%4.5205 of 5 stars2.72$105.12 -6.5%29Positive News2.95%ILMNIllumina$76.42-6.7%4.7316 of 5 stars2.48$140.90 84.4%21Positive NewsGap Down2.81%SRPTSarepta Therapeutics$58.61-6.2%4.7905 of 5 stars2.83$163.18 178.4%23Analyst UpgradeOptions VolumeHigh Trading Volume2.71%VRTXVertex Pharmaceuticals$484.01+0.1%3.727 of 5 stars2.65$509.17 5.2%26Analyst ForecastPositive News2.33%TXG10x Genomics$7.97-9.9%4.6047 of 5 stars2.35$20.21 153.6%17News CoverageGap Down2.19%CDNACareDx$17.37-5.5%3.1855 of 5 stars2.57$31.83 83.3%7Positive NewsGap Down2.04%NTLAIntellia Therapeutics$6.89-5.6%4.3854 of 5 stars2.63$37.56 445.1%19Gap Up2.04%MYGNMyriad Genetics$8.41-4.4%3.887 of 5 stars2.20$20.89 148.4%15Analyst ForecastGap Down1.64%RCKTRocket Pharmaceuticals$5.56-11.7%4.4323 of 5 stars2.92$43.00 673.4%12News CoverageGap DownHigh Trading Volume1.47%QUREuniQure$9.75-8.2%2.4405 of 5 stars2.82$38.80 297.9%11Analyst ForecastAnalyst RevisionNews Coverage1.42%VIRVir Biotechnology$5.96-8.0%3.553 of 5 stars2.83$35.67 498.4%6Gap Down0.87%RGNXREGENXBIO$6.67-5.4%4.4573 of 5 stars2.86$32.78 391.4%7Gap Down0.81%VERVVerve Therapeutics$3.85-1.5%1.9827 of 5 stars3.00$20.67 436.8%5Gap Down0.78%FLGTFulgent Genetics$17.00-3.5%2.7444 of 5 stars2.00$16.00 -5.9%1Short Interest ↑Gap Down0.77%PACBPacific Biosciences of California$1.19-6.3%2.5728 of 5 stars2.54$2.46 106.6%13Short Interest ↓Gap Down0.66%SANASana Biotechnology$1.37-16.0%3.2166 of 5 stars2.86$10.80 688.3%7Gap DownHigh Trading Volume0.66%MRVIMaravai LifeSciences$2.10-5.0%4.5326 of 5 stars2.25$7.31 247.9%12Options VolumeGap Down0.58%TSVT2seventy bio$4.97+0.2%3.1481 of 5 stars2.38$6.67 34.1%80.54%ALLOAllogene Therapeutics$1.38-4.2%2.3514 of 5 stars2.90$9.29 573.1%10Gap Down0.38%SGMOSangamo Therapeutics$0.62-4.3%1.5483 of 5 stars2.67$5.17 730.3%6News CoverageGap Down0.26%EDITEditas Medicine$1.12-5.1%4.0636 of 5 stars2.07$6.83 510.1%14Gap Down0.19%CRBUCaribou Biosciences$0.79-8.7%2.9528 of 5 stars3.00$10.33 1,216.3%5Short Interest ↓Gap Down0.17%LYELLyell Immunopharma$0.47-8.8%3.6209 of 5 stars1.50$1.00 115.1%2Positive NewsGap Down0.00%SCLXScilex$0.28-4.3%2.0838 of 5 stars3.00$13.00 4,467.8%4Analyst ForecastNews CoverageGap Down This page (NASDAQ:GNOM) was last updated on 4/4/2025 by MarketBeat.com Staff From Our PartnersTrump Allies Confirm Exec Order 14024 Triggers Dollar CollapseExecutive Order 14024 is paving the way for irreversible damage to the dollar's value—threatening your wealth,...Priority Gold | SponsoredURGENT: Someone's Moving Gold Out of London...People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | SponsoredTrump Orders 'National Digital Asset Stockpile'‘Digital Asset Reserve’ for THIS Coin??? Get all the details before this story gains even more tractionCrypto 101 Media | SponsoredYour Retirement Is Caught in the CrossfireWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredUrgent Bitcoin alert for RIGHT NOWFormer billion-dollar hedge fund manager Larry Benedict has released the most incredible presentation of his 4...Brownstone Research | SponsoredTrump’s Secret WeaponPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | SponsoredCrypto’s crashing…but we’re still profitingMost traders are panicking right now. Bitcoin’s dropping. Altcoins are bleeding. The stock market’s a mess....Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Global X Genomics & Biotechnology ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Global X Genomics & Biotechnology ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy GNOM Stock Free GNOM Stock Alerts